Barclays lowered the firm’s price target on Integral Ad Science to $16 from $17 and keeps an Equal Weight rating on the shares. The analyst sees pressure for the shares in the short-term post the Q4 report. Management did not provide much tangible data for the Meta brand safety opportunity, which is something investors were hoping for, the analyst tells investors in a research note. In addition, Integral talked about pricing pressure for some large renewals which partially drove the guidance miss, says the firm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IAS:
- IAS Reports Fourth Quarter and Full Year 2023 Financial Results
- Integral Ad expands AI-driven safety and suitability measurement to Meta
- Integral Ad Science initiated with a Buy at BofA, sees long runway for growth
- Integral Ad Science initiated with a Buy at BofA
- ‘2024 Will Be a Breakout Year for AdTech,’ According to BMO — Here Are 3 Stocks to Take Advantage